Jan 12, 2022 / 02:00PM GMT
Unidentified Analyst -
Good morning, everyone. Welcome to day 3 of the JPMorgan Healthcare Conference. This is [Julia Ching] from Life Science team at JPMorgan, and it's my great pleasure to introduce you to our next company presentation by Olink.
Just as a reminder, if you have a question, you can submit it through the website. And with that, let me turn it over to Jon.
Jon Heimer - Olink Holding AB(publ)-CEO&Director
Thank you very much, Julia, and good morning, everyone. Firstly, I want to thank our dear friends at JPMorgan inviting me to present here today. I really look forward to meeting all of you in person and have planned for an in-person event, but very much appreciate the invitation and the opportunity to speak with everyone here today.
My name is Jon Heimer. This year, I complete 30 years as a serial entrepreneur in the biotech device and drug development space. I was part of founding Olink in 2016 and been its CEO since inception.
I reminded to everyone today that I'll be
Olink Holding AB (publ) at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers